Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
208
Open
193.40
Bid (Size)
193.60 (1)
Ask (Size)
195.70 (1)
Prev. Close
193.40
Today's Range
193.40 - 193.40
52wk Range
135.85 - 194.99
Shares Outstanding
N/A
Dividend Yield
3.06%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
August 15, 2024
These three stocks to buy now will protect your portfolio if the S&P 500 crashes again regardless of whether there is a recession or not.
Via
InvestorPlace
Topics
Economy
Stocks
Exposures
Economy
US Equities
Performance
YTD
+21.01%
+21.01%
1 Month
+14.30%
+14.30%
3 Month
+17.68%
+17.68%
6 Month
+9.52%
+9.52%
1 Year
+27.61%
+27.61%
More News
Read More
Decoding AbbVie's Options Activity: What's the Big Picture?
August 14, 2024
Via
Benzinga
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Via
Benzinga
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
August 12, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
August 02, 2024
Via
Benzinga
A Closer Look at AbbVie's Options Market Dynamics
July 31, 2024
Via
Benzinga
3 Stocks Retirees Should Absolutely Love
August 10, 2024
Via
The Motley Fool
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
August 09, 2024
Via
FinancialNewsMedia
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
August 08, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Warren Buffett's Approach To Investing In Election Years
August 07, 2024
Via
Benzinga
Elliott Wave Technical Analysis: AbbVie Inc.
August 07, 2024
Via
Talk Markets
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
Via
PressReach
Exposures
Product Safety
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
August 06, 2024
Via
Benzinga
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
Via
Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
Via
The Motley Fool
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
Via
Benzinga
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early
July 31, 2024
Via
Investor's Business Daily
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
July 31, 2024
Via
InvestorPlace
7 Stocks Set for a Major Bull Run
July 31, 2024
Via
InvestorPlace
3 Powerhouse Growth Stocks to Load Up On During This Bull Market Cycle
July 31, 2024
Via
InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
Via
Benzinga
AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
July 30, 2024
Via
MarketBeat
Topics
Earnings
Intellectual Property
Exposures
Financial
Intellectual Property
Pharma Stock Cuts Earnings Outlook: Still a Buying Opportunity
July 30, 2024
Via
MarketBeat
3 High-Yield Dividend Stocks That Are Looking Super Hot
July 29, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.